{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:58:23Z","timestamp":1783781903827,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"RIKEN junior Research Associate Program"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejso.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T11:35:02Z","timestamp":1598268902000},"page":"394-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5282-5678","authenticated-orcid":false,"given":"Tomoaki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0575-0308","authenticated-orcid":false,"given":"Hideya","family":"Kawaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Murakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Hayashizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Yabushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusei","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-8114","authenticated-orcid":false,"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.08.005_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.08.005_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00000658-199801000-00011","article-title":"Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases","volume":"227","author":"Madariaga","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.08.005_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0039-6060(98)70249-1","article-title":"Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?","volume":"123","author":"Miyazaki","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2020.08.005_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/13651820500373010","article-title":"Surgical management of hilar cholangiocarcinoma: the Nagoya experience","volume":"7","author":"Nishio","year":"2005","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2020.08.005_bib5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1245\/ASO.2006.05.053","article-title":"Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor)","volume":"13","author":"Dinant","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.005_bib6","first-page":"7","article-title":"Segmental liver resections for hilar cholangiocarcinoma","volume":"45","author":"Nagino","year":"1998","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.ejso.2020.08.005_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archsurg.137.1.69","article-title":"Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer","volume":"137","author":"Yoshida","year":"2002","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejso.2020.08.005_bib8","article-title":"Differences in prognostic factors and recurrence patterns after curative-intent resection of perihilar and distal cholangiocarcinomas","volume":"1457496919832150","author":"Sallinen","year":"2019","journal-title":"Scand J Surg"},{"key":"10.1016\/j.ejso.2020.08.005_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.ejso.2015.05.013","article-title":"Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors?","volume":"41","author":"Ercolani","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.005_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/13651820802276630","article-title":"Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions","volume":"10","author":"Allen","year":"2008","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2020.08.005_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12876-016-0444-1","article-title":"Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma","volume":"16","author":"Ahn","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejso.2020.08.005_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jhep.2016.09.010","article-title":"Epithelial-mesenchymal transition in cholangiocarcinoma: from clinical evidence to regulatory networks","volume":"66","author":"Vaquero","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2020.08.005_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.ejso.2020.08.005_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"Huber","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ejso.2020.08.005_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2004.08.013","article-title":"Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer","volume":"574","author":"Sgarra","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejso.2020.08.005_bib16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2353\/ajpath.2009.080523","article-title":"HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells","volume":"174","author":"Watanabe","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejso.2020.08.005_bib17","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.febslet.2007.06.072","article-title":"DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells","volume":"581","author":"Li","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejso.2020.08.005_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/376771a0","article-title":"Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C","volume":"376","author":"Zhou","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2020.08.005_bib19","first-page":"2439","article-title":"High level expression of the HMGI (Y) gene during embryonic development","volume":"13","author":"Chiappetta","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.ejso.2020.08.005_bib20","first-page":"4075","article-title":"Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer","volume":"11","author":"Gong","year":"2019","journal-title":"Canc Manag Res"},{"key":"10.1016\/j.ejso.2020.08.005_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-0777-0","article-title":"Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway","volume":"14","author":"Zhao","year":"2016","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.ejso.2020.08.005_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canlet.2016.04.005","article-title":"Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer","volume":"376","author":"Wu","year":"2016","journal-title":"Canc Lett"},{"key":"10.1016\/j.ejso.2020.08.005_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejso.2011.01.004","article-title":"Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer","volume":"37","author":"Yang","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.005_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2012.05.001","article-title":"The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasiveness","volume":"44","author":"Rizzi","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2020.08.005_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijsu.2015.10.031","article-title":"HMGA1\/HMGA2 protein expression and prognostic implications in gastric cancer","volume":"24","author":"Jun","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2020.08.005_bib26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/his.13310","article-title":"Prevalence and significance of HMGA2 expression in oesophageal adenocarcinoma","volume":"71","author":"Mito","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2020.08.005_bib27","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.2147\/OTT.S116953","article-title":"High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma","volume":"9","author":"Na","year":"2016","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.ejso.2020.08.005_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102473","article-title":"HMGA2 contributes to distant metastasis and poor prognosis by promoting angiogenesis in oral squamous cell carcinoma","volume":"20","author":"Sakata","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2020.08.005_bib29","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1158\/1078-0432.CCR-10-2542","article-title":"Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers","volume":"17","author":"Wang","year":"2011","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejso.2020.08.005_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.suronc.2019.01.013","article-title":"The expressions of HMGA2 and Thy 1 in extrahepatic cholangiocarcinoma and their clinicopathological significances","volume":"29","author":"Liu","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.005_bib31","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.ejso.2019.06.014","article-title":"Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: should they be recognized as perihilar cholangiocarcinoma or differentiated?","volume":"45","author":"Lu","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.005_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00595-016-1362-0","article-title":"The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival","volume":"47","author":"Wellner","year":"2017","journal-title":"Surg Today"},{"key":"10.1016\/j.ejso.2020.08.005_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.14312\/2397-6845.2016-8","article-title":"Roles of HMGA proteins in cancer: expression, pathways, and redundancies","volume":"1","author":"G","year":"2016","journal-title":"Journal of Modern Human Pathology"},{"key":"10.1016\/j.ejso.2020.08.005_bib34","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1074\/jbc.M111.291385","article-title":"Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition","volume":"287","author":"Tan","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ejso.2020.08.005_bib35","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-12-3848","article-title":"HMGA2 is a driver of tumor metastasis","volume":"73","author":"Morishita","year":"2013","journal-title":"Canc Res"},{"key":"10.1016\/j.ejso.2020.08.005_bib36","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.4161\/cc.9.12.12050","article-title":"Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes","volume":"9","author":"Fuxe","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejso.2020.08.005_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/emmm.201201320","article-title":"WNT10B\/beta-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer","volume":"5","author":"Wend","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ejso.2020.08.005_bib38","first-page":"2877","article-title":"The Wnt-beta-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion","volume":"126","author":"Cai","year":"2013","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.ejso.2020.08.005_bib39","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1038\/onc.2012.573","article-title":"Stat 3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition","volume":"32","author":"Guo","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejso.2020.08.005_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/emboj.2008.294","article-title":"Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7","volume":"28","author":"Dangi-Garimella","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/j.ejso.2020.08.005_bib41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1158\/1078-0432.CCR-13-1452","article-title":"Frequent overexpression of HMGA2 in human atypical teratoid\/rhabdoid tumor and its correlation with let-7a3\/let-7b miRNA","volume":"20","author":"Zhang","year":"2014","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejso.2020.08.005_bib42","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/en.2012-1745","article-title":"Distinct expression patterns predict differential roles of the miRNA-binding proteins, Lin28 and Lin28b, in the mouse testis: studies during postnatal development and in a model of hypogonadotropic hypogonadism","volume":"154","author":"Gaytan","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejso.2020.08.005_bib43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ng.392","article-title":"Lin28 promotes transformation and is associated with advanced human malignancies","volume":"41","author":"Viswanathan","year":"2009","journal-title":"Nat Genet"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320306971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320306971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:35:01Z","timestamp":1760060101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320306971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0748798320306971"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.08.005","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}